Fungal infections – Page 15

Odontogenic-onset mucormycosis: A case series from a tertiary care institute in North India

mycolabadmin

This study describes five cases of a serious fungal infection called mucormycosis that started in the mouth following dental procedures like tooth extraction. All patients had uncontrolled diabetes, which made them vulnerable to this infection. The infection was treated with antifungal medications and surgery, with good recovery. The findings highlight how important it is for dentists to follow strict hygiene practices and for diabetic patients to keep their blood sugar controlled before dental work.

Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal)

mycolabadmin

This study examined fungal ear infections in a hospital in Senegal and found that about 85% of suspected cases were actually caused by fungi. The most common fungi were Aspergillus and Candida species. The research shows that itching was the main symptom associated with fungal ear infections, and that proper diagnosis is important to avoid unnecessary antibiotic use and provide better treatment.

Schizophyllum commune infection following chimeric antigen receptor T-cell therapy in a patient with lymphoma

mycolabadmin

A 71-year-old woman receiving CAR T-cell therapy for lymphoma developed a rare fungal lung infection caused by Schizophyllum commune six months after treatment. The infection presented similarly to other fungal diseases affecting the lungs and was diagnosed through bronchoscopy and fungal culture despite negative blood antibody tests. Standard antifungal medication (voriconazole) taken by mouth for four months completely resolved the infection, highlighting the need to consider rare fungi in patients receiving advanced cancer immunotherapies.

An Atypical Presentation of Allergic Bronchopulmonary Aspergillosis

mycolabadmin

A 57-year-old man without prior lung problems developed a persistent cough and breathing difficulties that didn’t respond to antibiotics. Imaging showed his lung had collapsed and fluid had accumulated around it, raising concerns about cancer. However, bronchoscopy revealed the collapse was caused by thick mucus plugs filled with Aspergillus fungus rather than cancer. After treatment with antifungal medication and steroids, the patient fully recovered with his lung re-expanding and fluid resolving.

Disseminated sporotrichosis caused by Sporothrix brasiliensis with testicular involvement

mycolabadmin

This case report describes a rare fungal infection caused by Sporothrix brasiliensis in a 35-year-old man living with HIV/AIDS. The infection spread throughout his body, affecting his skin, lungs, brain, and testicles. Doctors initially thought the testicular involvement was cancer and removed the testicle, but lab tests confirmed it was a fungal infection. The patient was successfully treated with antifungal medications and remains disease-free one year later.

Past, present and future of antifungals: Advancements in mechanisms of action and resistance

mycolabadmin

Fungal infections are a growing global health problem, particularly for people with weakened immune systems, causing millions of deaths annually. Current antifungal medications are limited and increasingly ineffective due to drug-resistant fungi. This special issue explores new treatment strategies including novel drugs, combination therapies, and innovative approaches like nanoparticles and antimicrobial peptides to combat these serious infections.

Saksenaea oblongispora Rhinosinusitis in Advanced HIV: A Rare and Lethal Mucormycosis

mycolabadmin

A 32-year-old man with advanced HIV developed a severe fungal infection of his sinuses caused by a rare fungus called Saksenaea oblongispora, which typically doesn’t affect people with HIV. The patient presented with severe facial swelling that rapidly worsened, and despite doctors identifying the fungus through biopsies and lab tests, he did not receive antifungal treatment or surgery before his condition became critical. This is the first case of this particular fungal infection documented in sub-Saharan Africa and in HIV patients, highlighting how dangerous this rare infection can be and how challenging it is to diagnose quickly enough to save lives.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Mucormycosis is a serious fungal infection that primarily affects people with weak immune systems and carries high mortality rates. Researchers studied three common mucormycosis-causing fungi to understand how their outer cell layers interact with the human immune system. They found that all three fungi trigger strong inflammatory responses, which may explain why the disease is so damaging. This research helps us better understand how these infections work and could lead to improved treatments or vaccines.

Dual-Emission FRET-PCR Outperforms SYBR Green and EvaGreen for Accurate Discrimination of Primary Canine Dermatophytes: Microsporum canis, Nannizzia gypsea, and Trichophyton mentagrophytes

mycolabadmin

This research developed a new rapid test called FRET-PCR that can identify three common fungal infections in dogs within 2.5 hours, compared to 2-4 weeks for traditional culture methods. The test works by detecting specific genetic markers in fungal DNA and measuring temperature changes that differ for each fungal species. When compared to two other molecular tests (SYBR Green and EvaGreen), the FRET-PCR method was more accurate and sensitive, even able to detect a single copy of the target gene. This faster, more accurate identification will help veterinarians choose the right treatment more quickly and prevent spread of fungal infections.

First human case of Eidernor doerrieniae colonization in a peritoneal dialysis catheter: A warning from silent contamination

mycolabadmin

A 52-year-old man on peritoneal dialysis noticed brownish particles in his dialysis catheter. Doctors identified the particles as a rare fungus called Eidernor doerrieniae, which had never been found in humans before. Although the patient had no symptoms, doctors immediately removed the catheter and treated him with antifungal medications, which successfully cured the infection. This case shows why patients and doctors should take visible particles in dialysis catheters seriously, even when there are no obvious signs of infection.

Research Topic: Fungal infections